By Marie Rosenthal
The Department of Health and Human Services amended the COVID-19 Public Readiness and Emergency Preparedness (PREP) Act declaration to allow licensed pharmacists to order and administer selected COVID-19 therapeutics, including subcutaneous monoclonal antibodies (mAbs).
The amendment broadly addresses COVID-19 therapeutics given orally, subcutaneously or intramuscularly, including current and future medications that are approved, authorized, cleared or licensed to